Innate and adaptive immune response in SARS-CoV-2 infection-Current perspectives. Article

Zhu, Qiugang, Xu, Yan, Wang, Ting et al. (2022). Innate and adaptive immune response in SARS-CoV-2 infection-Current perspectives. . FRONTIERS IN IMMUNOLOGY, 13 1053437. 10.3389/fimmu.2022.1053437

cited authors

  • Zhu, Qiugang; Xu, Yan; Wang, Ting; Xie, Feiting

authors

abstract

  • Coronavirus disease 2019 (COVID-19) has been a global pandemic, caused by a novel coronavirus strain with strong infectivity, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). With the in-depth research, the close relationship between COVID-19 and immune system has been dug out. During the infection, macrophages, dendritic cells, natural killer cells, CD8+ T cells, Th1, Th17, Tfh cells and effector B cells are all involved in the anti-SARS-CoV-2 responses, however, the dysfunctional immune responses will ultimately lead to the excessive inflammation, acute lung injury, even other organ failure. Thus, a detailed understanding of pertinent immune response during COVID-19 will provide insights in predicting disease outcomes and developing appropriate therapeutic approaches. In this review, we mainly clarify the role of immune cells in COVID-19 and the target-vaccine development and treatment.

publication date

  • January 1, 2022

published in

keywords

  • Adaptive Immunity
  • CD8-Positive T-Lymphocytes
  • COVID-19
  • Humans
  • Pandemics
  • SARS-CoV-2
  • immune responses
  • treatment
  • vaccination

Location

  • Switzerland

Digital Object Identifier (DOI)

start page

  • 1053437

volume

  • 13